Literature DB >> 10851707

[Effectiveness of special stroke units in treatment of acute stroke].

T Nikolaus1, M Jamour.   

Abstract

BACKGROUND: In Germany the implementation of specialized wards for the care of stroke patients is proposed. However, which type of organized inpatient stroke unit care is most effective and which group of patients will benefit most remains unclear.
METHODS: Based on the analyses of the Stroke Unit Trialists' Collaboration this paper reports results of randomized and quasi-randomized trials that compared organized inpatient (stroke unit) care with contemporary conventional care. The primary analyses examined death, dependency and institutionalization. Secondary outcome measures included patient quality of life, patient and carer satisfaction and length of stay in hospital and/or institution.
RESULTS: The analysis of twenty trails with 3864 patients showed a reduction in the rate of deaths in the stroke unit group as compared with the control group (OR 0.83, 95% CI 0.71-0.97). The odds of death or institutionalized care were lower (OR 0.76, 95% CI 0.65-0.90) as were death or dependency (OR 0.75, 95% CI 0.65-0.87). The results were independent of patient age, sex, stroke severity, and type of stroke unit organization.
CONCLUSION: Organized care in stroke units resulted in benefits for stroke patients with regard to survival, independence, and probability of living at home. However, these results refer exclusively to Anglo-American and Scandinavian trials. German stroke unit services are organized in a different way. No data about the effectiveness of the German model is yet available.

Entities:  

Mesh:

Year:  2000        PMID: 10851707     DOI: 10.1007/s003910050165

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  1 in total

Review 1.  Current Endovascular Approach to the Management of Acute Ischemic Stroke.

Authors:  Rakesh Khatri; Anantha R Vellipuram; Alberto Maud; Salvador Cruz-Flores; Gustavo J Rodriguez
Journal:  Curr Cardiol Rep       Date:  2018-05-07       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.